AzTrials
AzTrials

PRESSURE PAIN THRESHOLDNCT04263077

The Effect of Kinesio Taping Tension on the Pain Threshold and Tolerance

A study testing 50% TENSION GROUP, 75% TENSION GROUP and 100% TENSION GROUP in people with PRESSURE PAIN THRESHOLD and PAIN TOLERANCE, run by Muğla Sıtkı Koçman University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study was to investigate the effects of kinesiotape technique applied in different tensions on pain tolerance (PT) of healthy university students. 100 healthy and volunteer male individuals studying at Mugla Sitki Kocman University Faculty of Health Sciences will participate in the research. Read more about this study

Who is it for?
Ages 18 to 24 years, men onlyHealthy volunteers can take part
What is being tested?
50% TENSION GROUP, 75% TENSION GROUP and 100% TENSION GROUP
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
100 participants
Where
1 siteTurkey (Türkiye)
Study dates
18 Nov 2018to 1 Aug 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 24 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Being a male university student over the age of 18
  • Volunteering for the study
  • Filling out the informed consent form Not having the knowledge and experience about kinesiotaping before

Who cannot join

  • Being diagnosed with lateral epicondylit and its treatment
  • Having any neurological disease or systemic disease that disrupts sense / pain perception (diabetes, rheumatoid arthritis, peripheral vascular disease, etc.)
  • Skin sensitivity to elastic banding
  • Open wound, ulcer, fungal infection in the area to be taped
  • Exposure to upper extremity and / or cervical injury in the past 6 months

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Mugla Sitki Kocman University Health Sciences Faculty

    Muğla, 48000

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Kinesio Taping Tension on the Pressure-pain Threshold and Pain Tolerance: a Randomized Controlled Trial

The aim of this study was to investigate the effects of kinesiotape technique applied in different tensions on pain tolerance (PT) of healthy university students. 100 healthy and volunteer male individuals studying at Mugla Sitki Kocman University Faculty of Health Sciences will participate in the research. Study protocol was approved by the ethics committee of Mugla Sitki Kocman University. The study is designed as a randomized, controlled, double-blind study to be performed on 4 groups consisting of 25 individuals in each group (No tension(Placebo), and 50%, 75%, 100% tensions of Kinesiotape). Kinesiotape will be applied over lateral epicondyle of the dominant extremities with diamond shape technique by a KTAI®certified physiotherapist. PT's will be measured with J-Tech algometer before, immediately and 30 minutes after taping by a different physiotherapist who will be blind to taping tension.

Read the detailed description

Diamond shape banding method will be applied in a way that 4 bands of 2.5 cm width cut kinesio tape ends on top of each other, leaving the lateral epicondyle region exposed while the elbows are slightly flexed in the supine position. In the groups where different tensions will be applied, the middle points of the tapes will be stretched according to the amount of tensions, and the ends will be taped over each other without tension.In the placebo group, the tapes of the tapes will be applied tensionlessly without overlapping each other. Algometer will be used in the assessment of pressure pain threshold and pain tolerance. Pain severity felt at the level of pain threshold and pain tolerance will be evaluated with the Visual Analogue Scale (VAS). All measurements will be made before taping, immediately after taping and 30 minutes after taping, will be repeated 3 times and their average values will be recorded. There will be a 60 second rest period between each trial to avoid temporal sensitization. Each assessment will be performed bilaterally by another physiotherapist who is blind to the band tension and has no experience with the kinesio banding technique.

Being tested
PLACEBO, 50% TENSION GROUP, 75% TENSION GROUP, 100% TENSION GROUP
Keywords
KINESIOTAPING

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PLACEBOOther

    The diamond shape technique, which is a kinesio tape technique, will be used in the lateral epicondyle region. The ends of the kinesiotapes will be applied tension-free without overlapping.

  • 50% TENSION GROUPOther

    Kinesiotape will be applied to the lateral epicondyle region with 50% tension.

  • 75% TENSION GROUPOther

    Kinesiotape will be applied to the lateral epicondyle region with 75% tension.

  • 100% TENSION GROUPOther

    Kinesiotape will be applied to the lateral epicondyle region with 100% tension.

Study groups in NCT04263077
Study groupRoleWhat they receive
PLACEBOPlacebo comparatorIN THE PLACEBO GROUP, THE ENDS OF THE TAPES WILL BE APPLIED NO TENSION WITHOUT OVERLAPPING EACH OTHER.
Receives: Other: PLACEBO
50% TENSION GROUPOtherKINESIOTAPE WILL BE APPLIED WITH 50% TENSION.
Receives: Other: 50% TENSION GROUP
75% TENSION GROUPOtherKINESIOTAPE WILL BE APPLIED WITH 75% TENSION.
Receives: Other: 75% TENSION GROUP
100% TENSION GROUPOtherKINESIOTAPE WILL BE APPLIED WITH 100% TENSION.
Receives: Other: 100% TENSION GROUP

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pressure Pain Threshold

    Study will be performed with 4 groups of 25 individuals, each of whom use the kinesiotape at different tensions. 0% tension application will be for Placebo, 50% tension application, 75% tension application 100% tension application. In groups with different tension banding, pressure pain threshold will be measured with algometer bilaterally. Measurements will be repeated 3 times and their average will be recorded.

    Measured: 10 minutes

  2. Pain Tolerance

    After measuring the pressure pain threshold, the pain tolerance of the same groups will be measured with an algometer. Measurements will be repeated 3 times and their average will be recorded.

    Measured: 10 minutes

  3. Visual Analog Scale

    Pain severity felt at the level of pain threshold and pain tolerance will be evaluated with the Visual Analogue Scale (VAS) bilaterally. The pain intensity created by the algometer probe end will be measured by VAS. The patients will mark the severity of their pain on a 100 mm line, one end of which is painless and the other end expressing unbearably severe pain. Values close to 0 mean that the pain is less, and values close to 100 indicate that the pain is high.The VAS assessment will be done immediately after each pressure pain threshold and pain tolerance measurements. Measurements will be repeated 3 times and their average will be recorded.

    Measured: 10 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Feb 2020
  2. Study start18 Nov 2018
  3. Primary completion17 Jan 2020
  4. Study completion1 Aug 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04263077
Sponsor's protocol ID
180176
Status last verified
Oct 2022
First submitted
5 Feb 2020
Last updated
4 Oct 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing 50% TENSION GROUP, 75% TENSION GROUP and 100% TENSION GROUP in people with PRESSURE PAIN THRESHOLD and PAIN TOLERANCE, run by Muğla Sıtkı Koçman University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pressure Pain Threshold (time frame: 10 minutes). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Oct 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in